Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 24 studies | 29% ± 10% | |
endothelial cell of artery | 12 studies | 46% ± 18% | |
capillary endothelial cell | 11 studies | 32% ± 16% | |
vein endothelial cell | 9 studies | 35% ± 22% | |
basal cell | 8 studies | 27% ± 11% | |
endothelial cell of vascular tree | 7 studies | 24% ± 8% | |
epithelial cell | 7 studies | 32% ± 18% | |
type I pneumocyte | 6 studies | 30% ± 12% | |
secretory cell | 6 studies | 17% ± 1% | |
luminal cell of prostate epithelium | 3 studies | 23% ± 2% | |
pancreatic ductal cell | 3 studies | 39% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
prostate | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3693.29 | 576 / 578 | 89% | 38.20 | 1031 / 1155 |
intestine | 96% | 923.16 | 926 / 966 | 90% | 34.09 | 472 / 527 |
stomach | 95% | 793.24 | 342 / 359 | 85% | 33.01 | 244 / 286 |
breast | 100% | 2503.02 | 458 / 459 | 73% | 21.31 | 812 / 1118 |
esophagus | 83% | 731.36 | 1194 / 1445 | 88% | 21.87 | 161 / 183 |
kidney | 90% | 650.04 | 80 / 89 | 78% | 73.00 | 700 / 901 |
brain | 82% | 736.49 | 2179 / 2642 | 83% | 21.29 | 585 / 705 |
pancreas | 72% | 372.10 | 236 / 328 | 92% | 34.41 | 164 / 178 |
uterus | 91% | 623.68 | 155 / 170 | 69% | 19.12 | 316 / 459 |
prostate | 87% | 554.00 | 214 / 245 | 61% | 13.30 | 308 / 502 |
bladder | 81% | 463.43 | 17 / 21 | 66% | 21.24 | 333 / 504 |
spleen | 100% | 988.38 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 3199.07 | 1195 / 1204 | 0% | 0 | 0 / 0 |
ovary | 31% | 182.39 | 56 / 180 | 66% | 16.72 | 284 / 430 |
blood vessel | 86% | 969.33 | 1150 / 1335 | 0% | 0 | 0 / 0 |
skin | 78% | 845.54 | 1419 / 1809 | 7% | 0.83 | 34 / 472 |
thymus | 55% | 308.81 | 358 / 653 | 27% | 3.69 | 162 / 605 |
tonsil | 0% | 0 | 0 / 0 | 73% | 14.82 | 33 / 45 |
heart | 68% | 424.19 | 588 / 861 | 0% | 0 | 0 / 0 |
muscle | 60% | 398.86 | 482 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 24% | 86.45 | 63 / 258 | 14% | 2.05 | 32 / 230 |
liver | 8% | 30.45 | 19 / 226 | 18% | 3.86 | 75 / 406 |
lymph node | 0% | 0 | 0 / 0 | 17% | 2.01 | 5 / 29 |
peripheral blood | 17% | 174.73 | 157 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046888 | Biological process | negative regulation of hormone secretion |
GO_0033574 | Biological process | response to testosterone |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0060298 | Biological process | positive regulation of sarcomere organization |
GO_0071389 | Biological process | cellular response to mineralocorticoid stimulus |
GO_0061051 | Biological process | positive regulation of cell growth involved in cardiac muscle cell development |
GO_0060385 | Biological process | axonogenesis involved in innervation |
GO_0030878 | Biological process | thyroid gland development |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0006885 | Biological process | regulation of pH |
GO_0014823 | Biological process | response to activity |
GO_0007267 | Biological process | cell-cell signaling |
GO_0042313 | Biological process | protein kinase C deactivation |
GO_0035050 | Biological process | embryonic heart tube development |
GO_0001516 | Biological process | prostaglandin biosynthetic process |
GO_0035094 | Biological process | response to nicotine |
GO_0035815 | Biological process | positive regulation of renal sodium excretion |
GO_0014824 | Biological process | artery smooth muscle contraction |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0042310 | Biological process | vasoconstriction |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_0060585 | Biological process | positive regulation of prostaglandin-endoperoxide synthase activity |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_1903537 | Biological process | meiotic cell cycle process involved in oocyte maturation |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0007585 | Biological process | respiratory gaseous exchange by respiratory system |
GO_0070294 | Biological process | renal sodium ion absorption |
GO_2001259 | Biological process | positive regulation of cation channel activity |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0043200 | Biological process | response to amino acid |
GO_0070101 | Biological process | positive regulation of chemokine-mediated signaling pathway |
GO_0001701 | Biological process | in utero embryonic development |
GO_0042482 | Biological process | positive regulation of odontogenesis |
GO_0071372 | Biological process | cellular response to follicle-stimulating hormone stimulus |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_2000273 | Biological process | positive regulation of signaling receptor activity |
GO_0010193 | Biological process | response to ozone |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0010737 | Biological process | protein kinase A signaling |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0072011 | Biological process | glomerular endothelium development |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_0097492 | Biological process | sympathetic neuron axon guidance |
GO_0007589 | Biological process | body fluid secretion |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0032308 | Biological process | positive regulation of prostaglandin secretion |
GO_0042474 | Biological process | middle ear morphogenesis |
GO_0030185 | Biological process | nitric oxide transport |
GO_0031583 | Biological process | phospholipase D-activating G protein-coupled receptor signaling pathway |
GO_0051216 | Biological process | cartilage development |
GO_0010460 | Biological process | positive regulation of heart rate |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0086101 | Biological process | endothelin receptor signaling pathway involved in heart process |
GO_0007205 | Biological process | protein kinase C-activating G protein-coupled receptor signaling pathway |
GO_0003100 | Biological process | regulation of systemic arterial blood pressure by endothelin |
GO_0051899 | Biological process | membrane depolarization |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0042554 | Biological process | superoxide anion generation |
GO_0014034 | Biological process | neural crest cell fate commitment |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0003357 | Biological process | noradrenergic neuron differentiation |
GO_0034392 | Biological process | negative regulation of smooth muscle cell apoptotic process |
GO_0042045 | Biological process | epithelial fluid transport |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_1902074 | Biological process | response to salt |
GO_0071548 | Biological process | response to dexamethasone |
GO_0051248 | Biological process | negative regulation of protein metabolic process |
GO_0001569 | Biological process | branching involved in blood vessel morphogenesis |
GO_0045987 | Biological process | positive regulation of smooth muscle contraction |
GO_0007005 | Biological process | mitochondrion organization |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0030072 | Biological process | peptide hormone secretion |
GO_0034696 | Biological process | response to prostaglandin F |
GO_0090023 | Biological process | positive regulation of neutrophil chemotaxis |
GO_0048675 | Biological process | axon extension |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0030195 | Biological process | negative regulation of blood coagulation |
GO_0001975 | Biological process | response to amphetamine |
GO_0071385 | Biological process | cellular response to glucocorticoid stimulus |
GO_0003253 | Biological process | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO_0046887 | Biological process | positive regulation of hormone secretion |
GO_0035810 | Biological process | positive regulation of urine volume |
GO_0043179 | Biological process | rhythmic excitation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0071398 | Biological process | cellular response to fatty acid |
GO_0043507 | Biological process | positive regulation of JUN kinase activity |
GO_0035994 | Biological process | response to muscle stretch |
GO_0072112 | Biological process | podocyte differentiation |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0050850 | Biological process | positive regulation of calcium-mediated signaling |
GO_0044321 | Biological process | response to leptin |
GO_0019229 | Biological process | regulation of vasoconstriction |
GO_0003094 | Biological process | glomerular filtration |
GO_1905653 | Biological process | positive regulation of artery morphogenesis |
GO_0001821 | Biological process | histamine secretion |
GO_0010613 | Biological process | positive regulation of cardiac muscle hypertrophy |
GO_0071373 | Biological process | cellular response to luteinizing hormone stimulus |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0060137 | Biological process | maternal process involved in parturition |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045321 | Biological process | leukocyte activation |
GO_0051771 | Biological process | negative regulation of nitric-oxide synthase biosynthetic process |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0044751 | Biological process | cellular response to human chorionic gonadotropin stimulus |
GO_0009953 | Biological process | dorsal/ventral pattern formation |
GO_1902287 | Biological process | semaphorin-plexin signaling pathway involved in axon guidance |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0086100 | Biological process | endothelin receptor signaling pathway |
GO_0045793 | Biological process | positive regulation of cell size |
GO_0014826 | Biological process | vein smooth muscle contraction |
GO_0061626 | Biological process | pharyngeal arch artery morphogenesis |
GO_0045840 | Biological process | positive regulation of mitotic nuclear division |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_1900182 | Biological process | positive regulation of protein localization to nucleus |
GO_0010827 | Biological process | regulation of glucose transmembrane transport |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0045178 | Cellular component | basal part of cell |
GO_0048237 | Cellular component | rough endoplasmic reticulum lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0005615 | Cellular component | extracellular space |
GO_0033093 | Cellular component | Weibel-Palade body |
GO_0005737 | Cellular component | cytoplasm |
GO_0030133 | Cellular component | transport vesicle |
GO_0031708 | Molecular function | endothelin B receptor binding |
GO_0005179 | Molecular function | hormone activity |
GO_0005125 | Molecular function | cytokine activity |
GO_0031707 | Molecular function | endothelin A receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | EDN1 |
Protein name | Endothelin-1 (Preproendothelin-1) (PPET1) [Cleaved into: Endothelin-1 (ET-1); Big endothelin-1] Endothelin-1 |
Synonyms | hCG_37405 |
Description | FUNCTION: Endothelins are endothelium-derived vasoconstrictor peptides (By similarity). Probable ligand for G-protein coupled receptors EDNRA and EDNRB which activates PTK2B, BCAR1, BCAR3 and, GTPases RAP1 and RHOA cascade in glomerular mesangial cells . Also binds the DEAR/FBXW7-AS1 receptor . Promotes mesenteric arterial wall remodeling via activation of ROCK signaling and subsequent colocalization of NFATC3 with F-actin filaments (By similarity). NFATC3 then translocates to the nucleus where it subsequently promotes the transcription of the smooth muscle hypertrophy and differentiation marker ACTA2 (By similarity). . |
Accessions | P05305 ENST00000379375.6 Q6FH53 |